TIAFT Versailles

Scientific Program

Monday 5 September 2022

Tuesday 6 September 2022

  • 8.15 am – 9.15 am: Performance-enhancing drugs and behaviour alteration (M Huestis & A Salomone)
  • 9.15 am – 10.15 am: New analytical approaches – 1 (M Concheiro & F Saint-Marcoux)
  • 10.45 am – 12.45 pm: Recreational drugs and behaviour alteration (S Pichini & A Verstraete)
  • 2 pm – 4 pm: Alternative specimens (C Jurado & P Kintz)
  • 4.30 pm – 6.30 pm: Clinical forensic toxicology (S Wille & H Maurer)
  • 6.30 pm – 6.50 pm : NPS open meeting (NPS committee)
  • 8.15 am – 6 pm: Posters

Wednesday 7 September 2022

  • 8.15 am – 10.15 am: Postmortem toxicology 1 (H Chung & D Gerostamoulos)
  • 8.15 am – 10.15 am: session 1 DPC SFTA in French (parallel session) (V Dumestre-Toulet & JP Goullé)
  • 10.45 am – 12.45 pm: Recent trends in screening procedures (D Favretto & I Ojanpera)
  • 10.45 am – 12.30 pm: session 2 DPC SFTA in French (parallel session) (AS Lemaire-Hurtel & JM Gaulier)
  • 2 pm – 4 pm: Metabolism and metabolomics (B Desharnais & M Augsburger)
  • 2 pm – 5.30 pm: Free topics SFTA in French (parallel session) (AL Pélissier & A Larabi)
  • 4.30 pm – 5.30 pm: Plants intoxications (M Martinez & N Lemos)
  • 8.15 am – 5 pm: Posters

Thursday 8 September 2022

  • 8.15 am – 10.15 am: Postmortem toxicology 2 (A Evans & D Isenschmid)
  • 10.15 am – 12.45 pm: New analytical approaches – 2 (M Swortwood & R Kronstrand)
  • 2 pm – 3 pm: Free topics (H Teixeira & J Beyer)
  • 8.15 am – 3.30 pm: Posters

Oral presentations (version .pdf) Poster presentations (version .pdf)

Oral presentations

Tuesday 6 September 2022 morning

Performance-enhancing drugs and behaviour alteration (M Huestis & A Salomone)

  • O1. Akgür SA. Cut-off dilemma: differences from the forensic and clinic perspective
  • O2. Sempio C. Acute effects of Cannabinoid Consumption on Endocannabinoid Levels
  • O3. Shimko KM. Prevalence and emergence of steroidal and non-steroidal anabolic agents in the Australian community measured through wastewater analysis
  • O4. Thiebot P. Corticoids identification in a lipolytic product promoted by two influencers
  • O5. Tou K. Complementary biomarker detection for bisphosphonate use in race horses

New analytical approaches – 1 (M Concheiro & F Saint-Marcoux)

  • O6. Birk L. Expanding the use of cork as biosorbent through the determination of new psychoactive substances in postmortem blood samples
  • O7. Desharnais B. Case studies in automation of forensic toxicology practices with R
  • O8. Gampfer T. A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay – Exemplified for nine compounds
  • O9. Gottardo R. Intentional and unintentional nitrite intoxications: a novel diagnostic strategy based on the direct ion determination by capillary electrophoresis
  • O10. Gunnar T. Wastewater-based epidemiology combined with forensic toxicological information: trends in drug use and impact of law enforcement activities

Recreational drugs and behaviour alteration (S Pichini & A Verstraete)

  • O11. Deventer MH. New generic ban evading synthetic cannabinoids shaking up the market?
  • O12. Grafinger KE. Investigation of the μ and κ-opioid receptor activation by eight new synthetic opioids using the [35S]-GTPγS assay: U-47700, isopropyl U 47700, U-49900, U-47931E, N-methyl U-47931E, U-51754, U-48520 and U-48800
  • O13. Di Rago M. Toxicity of heroin laced with synthetic opioid β-U10 and etizolam
  • O14. Lee D. Would CNS depressants cause paradoxical aggressive driving behaviors?
  • O15. Morais J. New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System
  • O16. Persson M. Characterisation of the monoamine transport inhibition of 28 new psychoactive stimulants
  • O17. Lo Faro AF. Human methylone, MDMA and metabolites’ plasma concentrations by a new LC-MS/MS method after controlled administration of methylone and MDMA
  • O18. Fabresse N. Serotonin syndrome onset following 25H-NBOH and MDPHP consumption: a case report
  • O19. Pulver B. Review of five years of comprehensive NPS analytics and insights into the substance identification workflow of the ADEBAR project
  • O20. Augsburger M. Interest of drug checking supply: results of 3 years of activity in Geneva

Tuesday 6 September 2022 afternoon

Alternative specimen (C Jurado & P Kintz)

  • O21. Adamowicz P. Can scene bloodstains be used to quantify drug concentration at the moment of injury?
  • O22. Busardò FP. Assessment of prenatal exposure to alcohol and gestational consumption by EtG testing in neonatal meconium and maternal hair and neonatal: first Italian national survey
  • O23. Cobo-Golpe M. Detection of hair metabolome changes in cocaine users using untargeted metabolomics
  • O24. Concheiro M. Fast and sensitive method for the determination of 17 designer benzodiazepines in hair by Liquid Chromatography Tandem Mass Spectrometry
  • O25. Dumitrascu C. Phosphatidylethanol in whole blood: a complementary biomarker to ethyl glucuronide in hair
  • O26. Hakim F. Added value evidence of a simultaneous determination of two phosphatidylethanol isoforms and ethylglucuronide in dried blood spots in forensic contexts
  • O27. Oliverio S. Impact of hemp-based cosmetic products on cannabis testing in hair
  • O28. Paniagua-González L. Driving Under the Influence of Drugs (DUID) profiling in Spain: data from oral fluid results between 2016 and 2022, including the effect of COVID-19 lockdown
  • O29. Ramirez Fernandez M. Passive exposure to cocaine on a professional level: importance of considering relevant interpretation parameters
  • O30. Rodda LN. Bladder wash as an alternative urine specimen for postmortem toxicology

Clinical & forensic toxicology (S Wille & H Maurer)

  • O31. Bellouard M. Extrapyramidal syndrome in a breastfed child, relevance of toxicological analysis
  • O32. Ferrari L. Massive intoxication due to cocaine adulterated with carfentanil
  • O33. Gesseck A. The analysis of drugs in neonates using an ad hoc oral fluid collection device to develop a prediction model for neonatal abstinence syndrome and provide maternal support
  • O34. Høiseth G. Possibility of falsely low levels of the alcohol marker phosphatidylethanol in patients with high alcohol consumption and hemolytic conditions
  • O35. Jacobs C. Adherence monitoring of antihypertensive drugs in finger prick blood microsamples – Development and validation of an analytical procedure
  • O36. Kuchar M. Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine (DCK) in Wistar rats
  • O37. Lamoriniere M. Coconut crab intoxication in New Caledonia from January 2016 to April 2022
  • O38. Morini L. Ethyl glucuronide in hair: a 5-years retrospective cohort study among drivers under the influence of psychoactive substances and alcohol
  • O39. Schumann J. An illicit drug early warning system in Victoria, Australia: the role of forensic toxicology in clinical casework
  • O40. Wartmann Y. Finding CYP2D6 activity biomarkers by correlating MDMA pharmacokinetic parameters to untargeted metabolomics data

Wednesday 7 September 2022 morning

Postmortem toxicology – 1 (H Chung & D Gerostamoulos)

  • O41. Ameline A. Fate of fentanyl after formalin-fixed tissues: about an authentic case and a stability study
  • O42. Bottinelli C. Analysis of human insulin and its therapeutic analogs by LC-HRMS: 4 years feedback and perspectives
  • O43. Bosman I. A case series of suicides by sodium azide ingestion
  • O44. Di Fazio V. Poisoning with atropine-based eye drops: an almost perfect murder?
  • O45. Doerr AA. Deadly monointoxication after ingestion of 4F-MDMB-BICA
  • O46. Elmsjö A. Postmortem metabolic fingerprinting in death investigations
  • O47. Favretto F. Chlopyrifos fatal intoxication: homicide or suicide?
  • O48. Gagen S. The significance in detecting and determining out-of-scope findings for volatile organic compounds in forensic casework
  • O49. Hikin L. Sodium nitrite poisoning; a case series of 15 fatalities
  • O50. Logan B. Increasing incidence of xylazine as a toxic adulterating substance in postmortem forensic toxicology casework

Recent trends in screening procedures (D Favretto & I Ojanpera)

  • O51. Griffeuille P. Ultrafast measurement of drugs using Probe Electrospray Ionization Mass Spectrometry (PESI-MS) and isotope dilution: an example with metformin
  • O52. Houzé P. Micro sampling, a new trend in toxicological screening?
  • O53. Janssens LK. Large-scale activity-based SCRA screening on patient serum samples: CB1 bioassay supported by machine learning
  • O54. Kebbabi C. What is the added value of liquid chromatography-tandem mass spectrometry for routine urine drug screening in clinical situations?
  • O55. Magny R. Synthetic cannabinoids identification in e-liquid and biological samples through molecular network approach
  • O56. Pichini S. The role of analytical pharmacotoxicology in adressing the main functions of the National Early Warning System on NPS
  • O57. Trobbiani S. A method for the sensitive targeted screening of synthetic cannabinoids and opioids in whole blood by LC-QTOF with simultaneous suspect screening using HighResNPS.com
  • O58. Ververi C. Phosphatidylethanol (Peth) in Dried Blood Spots: development, validation and comparison between LC-MS/MS and QTOF methods
  • O59. Wille S. Practical High Resolution Mass Spectrometry screening approach and propositions for adequate identification criteria as well as quality assurance and validation specifics
  • O60. Zarrouk E. Quantitative screening of pesticides and their metabolites in human matrices: are we ready to switch to high resolution mass spectrometry?

Wednesday 7 September 2022 afternoon

Metabolomic and metabolism (B Desharnais & M Augsburger)

  • O61. Elbourne M. Metabolomic analysis of equine urine to determine route of altrenogest administration
  • O62. Gerace E. Metabolic study of methoxpropamine (MXPr) in rats and determination of its metabolites in biological samples by UHPLC-QTOF-HRMS
  • O63. Giorgetti A. Synthetic cannabinoids carrying an ethyl ester moiety: human phase I metabolism and prevalence of 5F-EDMB-PICA and EDMB-PINACA
  • O64. Jinni Y. Investigation of metabolic biomarkers: a metabolomics approach
  • O65. Keen B. A statistical focus on doping using a metabolomics approach
  • O66. Kemenes K. Metabolism of the synthetic cathinone alpha-pyrrolidinoisohexanophenone in humans using UHPLC-MS-QToF
  • O67. Pelletier R. 4-Chloro-Pyrrovalerone in silico, in vitro, in vivo metabolism studies using molecular networking
  • O68. Scholz M. Metabolomics for determination of non-substance related sleepiness
  • O69. Verougstraete N. Identification of etazene metabolites in human urine by LC-HRMS
  • O70. Schwelm HM. 3-Methyl-PCP – in vitro and in vivo metabolism in humans and post-mortem investigation of a fatal intoxication

Plants intoxications (M Martinez & N Lemos)

  • O71. Gaillard Y. The crime was so perfect! So, why not another time?
  • O72. Gish A. Analytical strategy to document horse fatalities related to Oenanthe crocata poisoning
  • O73. Flament E. Determination of orellanine and muscarine in biological fluids in suspected or proven poisoning cases: about several cases
  • O74. Petzel-Witt S. A case of attempted murder using blue monkshood due to unfulfilled desires
  • O75. Vevelstad M. Plant toxin poisoning – a disguised diagnosis?

Thursday 8 September 2022 morning

Postmortem toxicology – 2 (A Evans & D Isenschmid)

  • O76. Kacinko S. Tetrahydrozoline: death by eyedrops
  • O77. Morley S. Is carbon monoxide testing required on all deaths in the elderly?
  • O78. Ojanperä I. Fatal concentrations of antidepressants and antipsychotics in post-mortem blood
  • O79. Orfanidis A.  Analysis, stability and distribution of pharmaceuticals and drugs of abuse over a period of one year in formalin-fixed liver and formalin solutions
  • O80. Rock KL. Detection of novel benzodiazepines in post-mortem cases
  • O81. Rygaard K. Citalopram and escitalopram in hair segments from deceased individuals with mental illnesses
  • O82. Schwelm HM. 5-Methylmethiopropamine (5-MMPA, mephedrene) – human metabolism and post-mortem investigation of a fatal intoxication
  • O83. Söderberg C. Postmortem reference concentrations of elements in blood and urine
  • O84. Walton S. N,N-Dimethylpentylone – An emerging NPS stimulant of concern in the United States
  • O85. Ward LJ. Can postmortem metabolomics be used as a tool in the identification of deaths attributed to hypoglycaemia

New analytical approaches – 2 (M Swortwood & R Kronstrand)

  • O86. Jurasek B. The versatility of the XRPD for the drug detection
  • O87. Luginbühl M. Addressing new possibilities and new challenges: automated nondestructive hematocrit normalization for Dried Blood Spots
  • O88. Mardal M. A new strategy for efficient retrospective data analyses for Designer Benzodiazepines in large LC-HRMS datasets
  • O89. Massano M. Wastewater surveillance for different classes of pharmaceutical drugs: focus on psychotropic drugs and their metabolites
  • O90. Moosmann B. A novel receptor binding-based assay to screen for opiates and (synthetic) opioids in human urine samples
  • O91. Müller A. Formation of ethyl glucuronide by beta-Glucuronidase
  • O92. Quireyns M. Temporal monitoring of pharmaceutical consumption using a wastewater-based epidemiologic approach
  • O93. Romolo FS. Nuclear techniques in forensic toxicology
  • O94. Schneider TD. Uncovering urine adulteration attempts in forensic toxicology: a LC-MS based proteomics approach
  • O95. Weinmann W. Optimization of DBS-self sampling for PEth in a drinking experiment with standard DBS cards and with a new design of volumetric DBS card

Thursday 8 September 2022 afternoon

Free topics (H Teixeira & J Beyer)

  • O96. Knapp-Gisclon A. Analysis of an ampoule found on a WW2 German soldier: poison or medicine?
  • O97. Green H. CB1 activity of three classes of synthetic cannabinoids and their metabolites – The tail needs to know what the head is doing
  • O98. Holt A. Impact of vaping ethanol on the Roadside Field Sobriety Test in a clinical setting
  • 099. Willeman T. New insights into buprenorphine and methadone related fatalities at therapeutic concentration: 11-year results from french national DRAMES Study
  • O100. Marillier M. Poisoning at the court of the Sun King, the Affair of the Poisons

Société Française de Toxicologie Analytique

Mercredi 7 septembre 2022

Cannabidiol : mise à jour des connaissances
(réglementaires, cliniques et analytiques) dans un contexte d’actualité

8h15 – 8h45 :     Accueil. L’émargement des participants est obligatoire.

8h45 -10h15: SFTA – DPCSession 1 (V Dumestre-Toulet & JP Goullé)
Approfondissement des connaissances

  • Pr Jean-Pierre Goullé. Règlementation
  • Pr Céline Verstuyft. Aspects pharmacologiques
  • Dr Bertrand Brunet. Aspects analytiques
  • Pr Nadine Attal. Expérimentation de Cannabis Thérapeutique

10h15-10h45 :        Pause-café

10h45 -12h30:   SFTA – DPCSession 2 (AS Lemaire-Hurtel & JM Gaulier)
Approfondissement des connaissances (Suite)

  • Dr Juliana Tournebize Cigarette électronique
  • Dr Laurie Gheddar  Sport et dopage

Table Ronde: Aspects pratiques Illustrations des problématiques par des mises en situation proposées par les orateurs (présentation de cas et/ou Frequently Asked Questions,) et des réponses à y apporter.
Echanges avec les participants

12h30 : Clôture session DPC

SFTA Session Thèmes libres (AL Pélissier & A Larabi)

  • O101. Aknouche F. Administration de 5-APB dans une discothèque en Nouvelle-Calédonie : description de deux cas
  • O102. André C. Myocardial infarction and cannabis consumption: two years of data collection in CHU Amiens-Picardie
  • O103. Arbouche N. Difficulties in interpreting a therapeutic blood concentration of insulin lispro in postmortem blood: a case report
  • O104. Becam J. Cocaine pediatric poisoning: a case series
  • O105. Blanchot A. Bariatric surgery and changes in metformin distribution: about a fatal case
  • O106. Dugues P. Targeted and untargeted screening of new psychoactive substances (NPS) and classical drugs of abuse in Paris using hair testing: A 10-years study (2012-2021)
  • O107. Grenier C. 2-MeOPP positive hair result in case of urapidil treatment
  • O108. Feisthauer E. Very bad deep… When the scuba tank smells like smoke
  • O109. Lelong J. When a toast becomes fatal, the story of two children and sodium fluoroacetate
  • O110. Monteil-Ganière C. LC-HRMS toxicological screening and biological sample preparation: evaluation of extraction by turbulent flow chromatography and protein precipitation procedures
  • O111. Salle S. Interest of nails analysis to investigate synthetic cannabinoid exposure? a case report
  • O112. Zebbiche Y. Identification des sources d’exposition au plomb : intérêt de l’analyse isotopique par ICP-MS

Poster Presentations

Posters can be displayed beginning Monday, September 5th at 12:00 p.m. (room Le Nôtre) and continuing throughout the meeting dates .
To facilitate installation, the poster number will be displayed on the dedicated panel.

Authors must pick up their posters after the coffee break on Thursday, September 8th, at 3.30 p.m.

P1Čabala R. Are the results of immunochemical screening of urine for synthetic cannabinoids affected by other common drugs? – Pilot statistical study on samples from detention prisons
P2Abdennour S. Cannabis poisoning in infants: a case report
P3Abdennour S. Development and validation of UPLC-UV-DAD method for the determination of oleandrin in Nerium oleander dried leaves collected in Eastern Algeria
P4Abdennour S. Pharmacokinetics of oleandrin after administration of a Nerium oleander extract in mice
P5Abdennour S. Validation of a colorimetric method for measuring urinary thiocyanates applicable to cyanide poisoning
P6Abdullah A. Phytochemical effects of genistein and daidzein on sex hormones and corticosterone in female adult rats exposed to Chlorpyrifos 
P7Abid AI. Liver as an alternative specimen for carbon monoxide detection when blood is unavailable
P8Aboutara N. One large beer, please! Synthesis of phosphatidylethanol 16:0/18:1 and 16:0/18:2 after consumption of low amounts of alcohol 
P9Akgür SA. Caution in workplace drug testing: controlled drugs
P10Akgür SA. Methyl alcohol intoxication and concomitant psychoactive substances in forensic cases
P11Alzeer S. Determination of caffeine and paraxanthine concentrations in urine samples of male clients in three Syrian gymnasiums
P12Andresen Bergström M. Drug analysis of residues from used syringes collected at a syringe exchange programme in Gothenburg, Sweden
P13Andresen-Streichert H. Ketamine in DUID cases in the greater Cologne area. A case series 
P14Arezki Boukerma K. Fatal cocaine poisoning in a body stuffer 
P15Arezki Y. Application of the Evidence MultiSTAT benchtop analyser to the fast (under 30 minutes), simultaneous, semi-quantitative determination of 29 drugs of abuse from one urine sample
P16Arnault A. Dramatical outcome following the consumption of a joint containing the synthetic cannabinoid MDMB-4en-PINACA: a case report
P17Avci Akca A. Analysis of drug-impregnated paper from English prisons between 2018 And 2020
P18Baik H. The method of detection ADB-BUTINACA in urine and application in forensic cases
P19Bambagiotti G. Effects of subtoxic 3-methylmethcathinone concentrations on neuronal cell electrical properties
P20Barguil Y. Hair cannabinoids for distinguishing acute psychosis from chronic psychosis in cannabis users with brief psychotic disorder
P21Berardinelli D. 4-Hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) in vitro human metabolism
P22Boumba V. Quantification of brorphine in saliva using Fabric Phase Sorptive Extraction (FPSE) and tandem LC-MS/MS 
P23Brown-Baxter N. Validation of Gas-Chromatography Mass-Spectrometry (GC-MS) qualitative method for detection of paraquat by sodium borohydride-platinum chloride chemical reduction
P24Brunetti P. Human metabolism of AP-238. A novel synthetic opioid spreading in the shadow of “fentalogues”
P25Burgueño MJ. Did they really drink alcohol? Key role of ethyl glucuronide and ethyl sulfate in blood and vitreous humour in the interpretation of postmortem alcohol findings
P26Byrska B. Chemical composition of Ayahuasca seized in Poland 
P27Castro MJ. Metronidazole: the new cocaine adulterant in Uruguay?
P28Cattell C. Automating DUID methods using robotics for Rapid High Throughput sample preparation – Analysis of Delta-9-Tetrahydrocannabinol and its major metabolite Delta-9-Tetrahydrocannabinol acid in whole blood
P29Chang HT. Identification of urinary biomarkers of synthetic cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID and BZO-CHMOXIZID from authentic urine samples in singapore
P30Chebli A. Literature review on pregabalin and the risk of addiction
P31Chèze M. Drug-facilitated crimes: do not forget to test for GHB in hair!
P32Cihlarova P. The UHPLC-MS/MS determination of ostarine in food supplements for athletes
P33Coopman V. High-resolution quadrupole time-of-flight mass spectrometry, a powerfull technique to include in analytical scheme for the identification of drugs and chemicals in seizures: a case study
P34Copeland C. China versus the world: impact of international drug policy on post-mortem stimulant detections in England, Wales and Northern Ireland
P35Coquerel A. Post-mortem delay and stress / hypoxia markers in the sudden infant death syndrome (SIDS)
P36Crump K. The emerging trend of suicide using nitrite/nitrate in Victoria, Australia 
P37Czarny J. Comparison of screening with the use of Biochip Array Technology to the direct analysis of 521 psychoactive compounds and their residues with the use of LC-MS/MS method – does it mean the end of an era for immunochemical research? 
P38Daglioglu N. The systematic investigation of the role of adulterants into the postmortem redistribution of heroin
P39Dalsgaard PW. Multi-library synchronization for suspect screening using LC-HRMS: the importance of InChIkeys
P40Déglon J. Quantification of phosphatidylethanol combining dried blood spots sampling with Orbitrap-based LC-HRMS platform: method validation and proficiency testing
P41Deventer MH. Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor 
P42Di Rago M. Rapid semi-automated simplified liquid extraction (SLE) and data processing for 43 drugs of abuse in oral fluid
P43Djamaa S. Intoxication accidentelle aux pesticides : à propos d’un cas
P44Djamaa S. Qualitative screening analysis of urine samples by GC-MS method: application in forensic toxicology
P45Dopierala A. Fatal intoxication involving 2,5-dimethoxy-4-chloroamphetamine (DOC): a case report
P46Dufayet L. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: data from the Île-de-France Toxic Death Surveillance System (DCTOX-IdF)
P47Eysseric H. Ethyl acetate from nail polish remover inhalation in a case of fatal voluntary intoxication
P48Fabris A. Development of a new green microextraction technique, Switchable Hydrophilicity Solvent-Based Homogenous Liquid–Liquid Microextraction, to analyze synthetic cannabinoids in plasma
P49Falck Jørgensen C. Quantification of endocannabinoids in human plasma
P50Fathy Ahmad W. Effects of tramadol abuse on plasma concentration of Leptin and Agouti Related Protein (AgRP)
P51Fearn D. First confirmation of synthetic cathinone N,N-dimethylpentylone in post-mortem sample in New Zealand using GC-MS/MS
P52Fogarty M. A novel approach to verifying and implementing a quantitative standard addition analysis of NPS drugs in forensic toxicology samples
P53Foray ME. Etude de l’interférence potentielle du cannabidiol (CBD) et de ses métabolites sur le dosage dans le plasma du delta-9-tétrahydrocannabinol (THC) et de ses métabolites par méthode LC-MS/MS
P54Franco Martins A. Quantitative evaluation of the composition of synthetic cannabinoid receptor agonists (SCRA) in infused papers and herbal materials seized in Brazilian prisons
P55Fung F. Reaching new sensitivity levels for the detection of fentanyl analogs and highly potent novel synthetic opioids in blood
P56Gao L. Drugs of abuse in meconium: analytical strategy and results
P57Gaugler S. High resolution, high accuracy non-targeted LC-HR-MS/MS Dried Urine Spot screening for drug of abuse testing 
P58Gaulier JM. Evaluation of analytical performances of a serum acetaminophen assay designed for round-the-clock use
P59Goh EML. In vitro approaches for the identification and characterization of urinary metabolite biomarkers of synthetic cannabinoid ADB-BUTINACA
P60Goyal K. Financial heist from counterfeit drug: a case Study from Delhi, India
P61Gunja N. Food-borne methemoglobinemia in children
P62Gys C. Development, validation and application of a GC-MS method for quantification of glucose and lactate in vitreous humor
P63Hansen SL. Postmortem investigation of more than 100 consecutive autopsy cases in femoral blood, cardiac blood, brain tissue and muscle tissue
P64Harper CE. Drugged driving investigation workflow and oral fluid testing used around the world: survey results of SOFT/AAFS drugs and driving and oral fluid committees
P65Hemmer S. Emergency toxicology analysis – Method development for the straightforward determination of total 70 drugs and metabolites in human blood plasma by LC-MSn
P66Hermetet C. 2,4-dinitrophenol (2,4-DNP) poisoning in young athletes: clinical description of chronic exposure and public health perspectives – Around a case report
P67Høiseth G. Nystagmus among amphetamine-impaired drivers
P68Huertas T. Cannabis recent use in sudden unexpected deaths
P69Humbert L. Dosage de gamma-hydroxy butyrate sur Dried Blood Spot (DBS) par chromatographie en phase supercritique 
P70Imran M. Quantitative analysis of phosphine in variety of biological samples from two cases of fatal poisoning 
P71Isenschmid D. Detected drugs in homicides: A tale of two cities – Chicago and Detroit
P72Janeckova L. Counterfeits of Xanax – combination of designer benzodiazepines clonazepam and flualprazolam 
P73Jannetto PJ. Fluoride toxicity: a tale of two sources
P74Janssens LK. Towards better understanding SCRAs and metabolites in recreational drug intoxications associated with 5F-MDMB-PICA use
P75Johansen JE. A review of nine years of NPS synthesis research projects supported by EUROSTARS
P76Jung Y. Contents of cannabinoids in commercial hemp seed oil capsules in Korea
P77Kang M. Nicotine poisoning-related deaths in Seoul Capital Area, Korea, 2014-2021
P78Kankaanpää A. Regional changes in stimulant drug use during COVID-19 pandemic in Finland: a wastewater study
P79Kappatos D. Development and application of a real-time integrated Drugs Surveillance System (iDSS) for NPS in New Zealand
P80Kaudewitz J. Accumulation of amphetamine in hair after contact with street amphetamine
P81Kaudewitz J. Detection of drugs and metabolites in hair before and after treatment with freely available agents chosen to effectively remove drugs from the hair matrix – a case study
P82Kernalléguen A. Identification and quantitation of kratom in the hair of a regular user of substances purchased on the darkweb
P83Kiat W. Chronic methanol toxicity through topical and inhalational routes presenting as vision loss: case report
P84Kikura-Hanajiri R. The differentiation of LSD and its 17 related compounds by GC-EI-MS and GC-CI-QTOF-MS
P85Kim E. Current status of hair analysis on narcotics in Korea
P86Kim JY. Simultaneous determination of cocaine, cocaethylene, benzoylecgonine and ethyl glucuronide in hair from the cocaine and alcohol abusers by LC-MS/MS
P87Kim M. Determination of cannabinoids in illegal e-cigarette fluids in Korea by LC-MS/MS
P88Kinani A. High throughput online solid-phase extraction tandem mass spectrometry for immunosuppressive drugs determination in whole blood
P89Kolderová N. Chiral separation and characterization of methoxphenidine – A popular street drug
P90Kronstrand R. Quantification of THC, metabolites, and related compounds in whole blood using LC-MS/MS
P91Lacoursière J. SAMHSA drug panel screening in oral fluid: development of screening method at 8 seconds per sample using LDTD-MS/MS
P92Lapo S. THC and THC-COOH hair concentrations: influence of age, gender, consumption habits, hair morphology and cosmetics treatment
P93Lendoiro E. Usefulness of toxicology screening by High Resolution Mass Spectrometry in methamphetamine and amphetamine users attended in Emergency Departments 
P94Lierheimer S. Comparison of electrospray and UniSpray™ ion sources with post-column hydrochloric acid infusion for 119 abuse relevant substances
P95Lindsay C. Form and content of Jamaican cannabis edibles
P96Liu H. New phosphatidylethanol (PEth) reference materials by chemical synthetic pathway
P97Lupo S. A multi-class drug and metabolite screen of 231 analytes by LC-MS/MS
P98Makanye L. Interdisciplinary approach to determining the use of drugs of abuse in wastewater using a survey and Gas Chromatography-Mass Spectrometry
P99Malaca S. In silico prediction, human hepatocyte metabolism, LC-HRMS/MS analysis, and targeted/nontargeted data-mining to characterize 4-acetoxy-N,N-diisopropyl-tryptamine metabolism
P100Malinescu B. Lethal intoxications of medical staff with substances used in the profession – presentation of a group of cases
P101Malokhat N. Development of methods of determination of biological liquids by high-performance liquid chromatography of acetamiprid pesticide
P102Mandour R. Domestic water and accumulating mercury toxicity in the kidney
P103Marikova T. Photocatalytic degradation of antibiotics under various conditions
P104Martin P. Synthesis of benzo-condensed cyclic cathinone derivatives
P105Mastrogianni O. Development and validation of a LC-MS/MS method for the determination of 25 drugs in cerumen and its application to real postmortem samples
P106Matheux A. Suicide of a young woman using a kit containing sodium nitrite ordered on the internet
P107Mathon C. Occurrence of GHB in blood and urine specimens from victims of alleged sexual assault or blackout in Western Switzerland
P108McCulloch M. The impact of imidacloprid and its metabolites on long–term neurodevelopmental and neurodegenerative disorders in a Zebrafish model
P109McMillan A. Automating DUID methods using robotics for rapid High Throughput Sample Preparation – Section 4 and Section 5A UK Road Traffic Act compounds in whole blood
P110Mcmillan D. Multi-panel detection of drugs and drug metabolites in hair samples using a comprehensive extraction method
P111Meda SD. Investigations toxicologiques dans un cas d’intoxication alimentaire collective d’une famille au Burkina Faso
P112Menendez MJ. Drug delivery homicide: a challenge for testimony from toxicologists 
P113Minji K. Determination of flupyradifurone and its metabolite in postmortem blood by liquid chromatography-tandem mass spectrometry
P114Mishra A. Development of new spot test for the identification of ketamine and its application for forensic samples – Blood, injection, and viscera
P115Mishra A. Qualitative and quantitative evaluation of the physiologically active substances in commercially available Withania Somnifera supplements
P116Mistry N. An alternative workflow for drug analysis
P117Monteiro C. Ethanol and putrefaction: medicolegal relevance of the study of different biological samples
P118Monti M. Chemical differentiation of cannabis varieties applying targeted and untargeted analysis
P119Morla A. Highly sensitive MS/MS detection for confident identification of potent novel synthetic opioids and their metabolites
P120Mubasher M. Exhumation unveiled honor killing of a woman in Pakistan
P121Mubasher M. Simultaneous quantitation of commonly encountered drugs (lidocaine, orphenadrine, chlorpheniramine and chloroquine) in biological specimens using modified QuEChERS technique
P122Musile G. Creatinine determination by origami paper-based device for identifying urine adulteration 
P123Muzikova B. The optimalization of photocatalytic degradation of 4-tert-octylphenol 
P124Najamuddin N. Detection of phosphine in abdominal cavity material of woman dead body and ingesta of cow using Gas Chromatography-Nitrogen Phosphorous Detector technique (GC-NPD)
P125Negri P. Enhancing high-resolution mass spectrometry performance for NPS analysis with improved sensitivity and characterization
P126Noritake K. Fatal intoxication with a mixture of para-methoxyamphetamine, N-ethylpentylone, and ketamine
P127Norman C. Newly emerging synthetic cannabinoids and novel modes of use of benzodiazepines in prisons: an update from the Scottish Prisons Non-Judicial Seizures Drug Monitoring Project
P128Oyono Y. Prevalence of alcohol among drivers, riders and pedestrians injured in road traffic crashes in Cameroon: a cross-sectional study
P129Papoutsis I. Study on the distribution of quetiapine and its metabolites in vitreous humor 
P130Park Y. Drug Trend Report 2017-2021 in Korea
P131Pascali J. Detection of multiple prohibited ingredients in nutritional supplements in a case of doping
P132Pasin D. Identification of the novel synthetic cannabinoid-type new psychoactive substance, CH-PIACA, in seized material
P133Pelissier-Alicot AL. Deaths related to the combination of pregabalin and other drugs of abuse: about two cases
P134Peres M. Two deaths after ingestion of a falsified pumpkin seed oil
P135Perrais M. Measurement of trace elements concentrations in human adipose tissue and links with phenotypic characteristics
P136Pinar EO. Evaluation of homogeneity in cocaine-impregnated papers: a pilot study
P137Proença P. LC-MS/MS-MS3 for determination and quantification of ∆9-tetrahydrocannabinol and metabolites in blood samples
P138Pulver B. Synthetic cannabinoids and their semi-systematic naming developed in Europe – Overview of the chemical diversity and practical guidelines
P139Pulver B. Synthetic cannabimimetics with cyclobutyl methyl and norbornyl methyl side chains – Pharmacological data and legislative implications
P140Rab E. Benefits of simultaneous screening and quantitation of drugs and their metabolites in post-mortem samples by liquid chromatography-high resolution mass spectrometry 
P141Rachedi IR. A case report: fatal intoxication by simultaneous abuse of cocaine and ethyl alcohol 
P142Rachedi IR. Acute toxicity due to delayed elimination of methotrexate in cancer therapy: a case report
P143Rana S. Cocaethylene presence in oral fluids from cocaine users
P144Resnik K. In vitro metabolic profile of the New Synthetic Opioid Bucinnazine by liquid chromatography tandem mass spectrometry (LC-MS/MS)
P145Reveil L. A determination of the aerosolization efficiency of drugs of abuse in a eutectic mixture with nicotine in electronic cigarettes
P146Riasat M. Sevoflurane analysis in forensic cases using Headspace-Gas Chromatography-Mass Spectrometry: a case study
P147Rodrigues LC. Use of solid phase microextraction in tips (SPME-Tips) for analysis of cocaine and biotransformation products in oral fluid by liquid chromatography tandem mass spectrometry (LC-MS/MS)
P148Rodrigues T. Prevalence of volatile organic compounds in forensic toxicology reports of São Paulo State 
P149Romolo FS. On-site GC-QEPAS analysis on the scene of crime: the RISEN project
P150Roussel O. Gliclazide poisoning: when hair analysis supports a dispensing error!
P151Rubbens J. Sample preparation and quantitative UHPLC-MS/MS analysis in an accredited high-throughput environment: tips and tricks to improve your success ratio
P152Russell S. A survey of eutylone prevalence in New Zealand during 2020 and 2021
P153Saka K. Simple and simultaneous quantification of cyanide, ethanol, and 1-propanol in blood by headspace GC–MS/NPD with a Deans switch
P154Salomone A. Assessment of recombinant beta-Glucuronidase vs native beta-Glucuronidase and alkaline conditions for the hydrolysis of THC-glucuronide 
P155Salvador A. Forensic profiling of methamphetamine concealed in chinese teabags seized from multiple drug operations in the Philippines: a case report
P156Sarkisian M. Identification criteria, in-house compound libraries and SWATH: a benchmark implementation of quadrupole time-of-flight mass spectrometry in routine toxicological casework 
P157Saskoy L. Back to the future: retrograde alcohol calculations an uncertain science
P158Saxena D. Partial hanging with multiple pesticide poisoning: a case report of a complex suicide
P159Sayaka N. An autopsy case of fatal insulin preparation overdose
P160Sekula K. Differentiation of cannabis types based on cannabinoid content
P161Shoff E. What once was old is new again: the emergence of traditional stimulants and hallucinogens in Miami-Dade County postmortem casework 
P162Sim J. A lethal case of 4F-MDMB-BINACA poisoning
P163Sinha S. Spontaneous Explosion due to Volatile Inflammable Chemicals – Invisible explosives
P164Skov K. Improving analysis of urine samples from drug-facilitated sexual assault cases
P165Stockham P. Characteristics of patients positive for methamphetamine in the emergency department, and the influence of the co-administration of GHB
P166Stopnitskiy A. Effects of modern hepatoprotector on condition of the liver indicators and central nervous systems of patients with alcoholic toxic hepatitis 
P167Sundermann TR. Cocaine derivatives – synthesis, analytical characterization and evaluation of their cross reactivity in immunochemical assays
P168Surenjav U. Prevalence of thyrotoxicosis in mongolia
P169Tanaka R. Analyses of LSD analogs in illegal products: the identification of 1cP-AL-LAD, 1cP-MIPLA and 1V-LSD
P170Taylor K. Review of findings in a case series of NPS benzodiazepines in UK deaths
P171Tini A. Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling (VAMS) and LC-MS/MS
P172Tonooka-Kubota K. Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of seventeen beta blockers
P173Toure A. Intoxications aux pesticides au Sénégal : données du centre Antipoison de 2009 à 2020
P174Tytgat J. Delta-8-Tetrahydrocannabinol, an emerging NPS and other structurally related cannabinoids
P175Usman HF. A fatal case of carbofuran and para-phenylenediamine poisoning: a death mystery resolved
P176Vagnerova M. Novel method for determination of methoxphenidine and its main metabolite in biological samples 
P177Vaiano F. Intoxication by drugs of abuse in paediatric age in Florence: a 5-years study
P178Van Wichelen N. Refining wastewater-based epidemiology for cannabis consumption monitoring: relevance of analysing both the aqueous phase and suspended solids of influent wastewater
P179Vancea S. 3,5-Dimethoxyphenol identification from urine by GC-MS after a lethal intoxication with Taxus baccata: a case report
P180Verma Y. Toxicity risk assessment in tobacco chewers, cigarette smokers and alcohol consumers using urinary DNA adduct and exfoliated buccal cells micronuclei as non invasive biomarkers 
P181Verougstraete N. First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne): a recent addition to the nitazene opioid subclass
P182Vikingsson S. Relative hydroxy-cocaine concentrations a possible marker for cocaine use?
P183Walle N. Can postmortem toxicological findings be influenced by a further release of fentanyl from transdermal patches? – A pilot study using the pig model
P184Webling K. Characterization of metabolites from 4CN-MDMB-BUTINACA and Benzyl-4CN-BUTINACA using human hepatocytes followed by LC-QTOF-MS analysis
P185Weinmann W. Dried blood spot (DBS) for ethyl glucuronide (EtG) and ethyl sulfate (EtS) determination in blood with a new design of “volumetric” DBS filter paper card
P186Yang CH. Designer benzodiazepines and their metabolites in post- and antemortem specimens: quantitation by UHPLC-MS/MS and findings in Taiwan
P187Yao YJ. Suicide by sodium nitrite – an emerging trend
P188Zakirdjan Y. Development of methods for separation of imidacloprid and acetamiprid from biological liquids
P189Zebbiche Y. Biomonitoring of exposure of algerian population to lead
P190Matey JM. What do we know about the positional isomers of 2C-B? Study through real hair cases: the role of high-resolution mass spectrometry (HRMS)